The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy

Journal of Periodontology

Volumn 77, Issue 3, 2006, Pages 357-363

  Lan, Jing ^a,b   Wang, Zhifeng ^a,b   Wang, Yining ^a   Wang, Jiawei ^a   Cheng, Xiangrong ^a  

^a WUHAN UNIVERSITY   (China)

^b People's Republic of China   (China)

Author keywords

Confocal laser scanning microscopy; Growth factors; Osseointegration

Indexed keywords

ALIZARIN; CALCEIN; FLUORESCENT DYE; METHACRYLIC ACID METHYL ESTER; POLYLACTIC ACID; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT SOMATOMEDIN C; TITANIUM; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; LACTIC ACID; POLYMER; RECOMBINANT PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE REGENERATION; BONE SCREW; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG POTENTIATION; FEMUR; HEALING; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOTOMY; PERIODONTAL DISEASE; RABBIT; TOOTH IMPLANTATION; ANIMAL; CONFOCAL MICROSCOPY; DRUG COMBINATION; DRUG EFFECT; HUMAN; IMPLANT; NONPARAMETRIC TEST;

ANIMALS; BONE MORPHOGENETIC PROTEINS; COATED MATERIALS, BIOCOMPATIBLE; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DRUG COMBINATIONS; DRUG SYNERGISM; FEMUR; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMPLANTS, EXPERIMENTAL; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MALE; MICROSCOPY, CONFOCAL; OSSEOINTEGRATION; POLYMERS; RABBITS; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646373939     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050016     Document Type: Article

References (45)

1. Rutherford RB, Sampath TK, Rueger DC, Taylor TD. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992;7:297-301.
2. Becker W, Lynch SE, Lekholm U, et al. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or dimineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992;63:929-940.
3. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implant. Results of a pilot study in beagle dogs. J Periodontol 1991;62:710-716.
4. Xiang W, Baolin L, Yan J, Yang X. The effect of bone morphogenetic protein on osseointegration of titanium implants. J Oral Maxillofac Surg 1993;51: 647-651.
5. Bessho K, Carnes DL, Cavin R, Chen HY, Ong JL. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res 1999;10: 212-218.
6. Tatakis DN, Koh A, Jin L, Wozney JM, Rohrer MD, Wikesjö UE. Peri-implant bone regeneration using recombinant human bone morphogenetic protein-2 in a canine model: A dose-response study. J Periodontal Res 2002;37:93-100.
7. Jung RE, Glauser R, Scharer P, Hammerle CH, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003; 14:556-568.
8. Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci USA 1987;84:7696-7700.
9. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84:640-646.
10. Knighton DR, Fiegel VD, Austin LL, Ciresi KF, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986;204:322-330.
11. Papalexiou V, Novaes AB, Grisi MF, Souza SS, Taba M, Kajiwara JK. Influence of implant microstructure on the dynamics of bone healing around immediate implants placed into periodontally infected sites. Clin Oral Implants Res 2004;15:44-53.
12. Suzuki K, Aoki K, Ohya K. Effects of surface roughness of titanium implants on bone remodeling activity of femur in rabbits. Bone 1997;21:507-514.
13. Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47.
14. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995;136:2671-2677.
15. Reddi AH. Bone morphogenesis protein: From basic science to clinical applications. J Bone Joint Surg Am 2001;83-A(Suppl.):S1-S6.
16. Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath T, ten Dijke P. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. J Bone Miner Res 1999;14:1145-1152.
17. Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res 1999;17:269-278.
18. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998;346:26-37.
19. Hogan BL. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996;10:1580-1594.
20. Barboza EP, Caula AL, Caula Fde O, et al. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 2004;75:702-708.
21. Rachmiel A, Aizenbud D, Peled M. Enhancement of bone formation by bone morphogenetic protein-2 during alveolar distraction: An experimental study in sheep. J Periodontol 2004;75:1524-1531.
22. Pang EK, Im SU, Kim CS, et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model. J Periodontol 2004;75:1364-1370.
23. Higuchi T, Kinoshita A, Takahashi K, Oda S, Ishikawa I. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999;70:1026-1031.
24. Matin K, Nakamura H, Irie K, Ozawa H, Ejiri S. Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: An experimental study in the rat. Int J Oral Maxillofac Implants 2001;16:400-411.
25. Jovanovic SA, Hunt DR, Bernard GW, et al. Long-term functional loading of dental implants in rhBMP-2 induced bone: A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003;14: 793-803.
26. Kinoshita A, Oda S, Takahashi K, Yokota S, Ishikawa I. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J Periodontol 1997;68: 103-109.
27. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjo UM. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995;66:131-138.
28. Sykaras N, Triplett RG, Nunn ME, Iacopino AM, Opperman LA. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 2001;12:339-349.
29. Canalis E, Gabbitas B. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J Bone Miner Res 1994;9:1999-2005.
30. Yeh LC, Adamo ML, Olson MS, Lee JC. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 1997;138:4181-4190.
31. Marie PJ, Debiais F, Hay E. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 2002;17:877-885.
32. Ohbayashi N, Shibayama M, Kurotaki Y, et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002;16:870-879.
33. Bonaventure J, El Ghouzzi V. Molecular and cellular bases of syndromic craniosynostoses. Expert Rev Mol Med 2003;5:1-17.
34. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003;316:23-32.
35. Aspenberg P, Lohmander S. Fibroblast growth factor stimulates bone formation: Bone induction study in rats. Acta Orthop Scand 1989;60:473-476.
36. Wang JS. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand 1996;269(Suppl.):1-33.
37. Inui K, Maeda M, Sano A, et al. Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif Tissue Int 1998;63:490-495.
38. Franke Stenport V, Johansson CB, Sawase T, Yamasaki Y, Oida S. FGF-4 and titanium implants: A pilot study in rabbit bone. Clin Oral Implants Res 2003;14:363-368.
39. Sato Y, Kikuchi M, Ohata N, Tamura M, Kuboki Y. Enhanced cementum formation in experimentally induced cementum defects of the root surface with the application of recombinant basic fibroblast growth factor in collagen gel in vivo. J Periodontol 2004;75: 243-248.
40. Kubota K, Iseki S, Kuroda S, et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 2002; 31:465-471.
41. Warren SM, Bruner LJ, Harland RM, Economides AN, Longaker MT. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-629.
42. Meraw SJ, Reeve CM, Lohse CM, Sioussat TM. Treatment of peri-implant defects with combination of growth factor cement. J Periodontol 2000;71:8-13.
43. Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004;34:402-411.
44. Debiais F, Hott M, Graulet AM, Marie PJ. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 1998;13:645-654.
45. Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factor (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 2000;149:1297-1308.